| Metric | Value ($ M) | Q3 FY24 |
|---|---|---|
| Revenue | 6.00 | 87.5% |
| Total Income | 6.00 | 87.5% |
| Expenditure | 148.00 | 3.3% |
| PBT | -135.00 | 46.7% |
| Net Profit | -135.00 | 46.7% |
| OPM | — | |
| NPM | — | |
| EPS | -1.27 | 27.0% |
Arcus Biosciences Announces Financial Results for Nine Months Ended Sept 30, 2025
04 May 2026 · 4 May, 8:43 am
Summary
Arcus Biosciences, Inc. issued a press release announcing its financial results for the nine months ended September 30, 2025. The full text of the press release is furnished as Exhibit 99.1.
Informational and educational content only. Not investment advice.